These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2854361)

  • 1. Release of granulocyte proteins during cardiopulmonary bypass: effect of different pharmacological interventions.
    Riegel W; Spillner G; Schlosser V; Lang K; Hörl WH
    Adv Exp Med Biol; 1988; 240():391-7. PubMed ID: 2854361
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels of main granulocyte components during cardiopulmonary bypass.
    Riegel W; Spillner G; Schlosser V; Hörl WH
    J Thorac Cardiovasc Surg; 1988 Jun; 95(6):1014-9. PubMed ID: 2836662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte superoxide anion and elastase release during cardiopulmonary bypass.
    Haga Y; Hatori N; Yoshizu H; Okuda E; Uriuda Y; Tanaka S
    Artif Organs; 1993 Oct; 17(10):837-42. PubMed ID: 8274101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extracellular release of granulocyte collagenase and elastase during phagocytosis and inflammatory processes.
    Ohlsson K; Olsson I
    Scand J Haematol; 1977 Aug; 19(2):145-52. PubMed ID: 197589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in serum activities of granulocyte elastase, pancreatic secretory trypsin inhibitor (PSTI) and beta glucuronidase in patients undergoing cardiopulmonary bypass].
    Doi H; Okutsu Y; Kitamura S; Numata K
    Masui; 1988 Mar; 37(3):344-51. PubMed ID: 3398213
    [No Abstract]   [Full Text] [Related]  

  • 6. The calcium channel blocker nifedipine fails to inhibit leucocyte elastase release during cardiopulmonary bypass.
    Massaut J; Hennebert N; Tasiaux N; Demanet H
    Acta Anaesthesiol Scand; 1993 Jan; 37(1):82-4. PubMed ID: 8424302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinical study of respiratory complication after cardiopulmonary bypass, with special reference to complement activation, WBC and granulocyte elastase].
    Nagamine S; Tabayashi K; Haneda K; Mohri H
    Nihon Geka Gakkai Zasshi; 1994 May; 95(5):348-53. PubMed ID: 8007941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.
    Borowiec J; Thelin S; Bagge L; Nilsson L; Venge P; Hansson HE
    J Thorac Cardiovasc Surg; 1992 Sep; 104(3):642-7. PubMed ID: 1325013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of myocardial ischaemia-reperfusion on granulocyte elastase release.
    Ceriana P
    Anaesth Intensive Care; 1992 May; 20(2):187-90. PubMed ID: 1595854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nifedipine inhibits granulocyte activation during cardiopulmonary bypass.
    Riegel W; Spillner G; Schlosser V; Hörl WH
    Klin Wochenschr; 1987 Jul; 65(12):581. PubMed ID: 3498087
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma levels of main granulocyte components during hemodialysis.
    Hörl WH; Riegel W; Steinhauer HB; Wanner C; Schollmeyer P; Schaefer RM; Heidland A
    Contrib Nephrol; 1987; 59():35-43. PubMed ID: 2832120
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring of factor XII activity and granulocyte elastase release during cardiopulmonary bypass.
    Irvine L; Sundaram S; Courtney JM; Taggart DP; Wheatley DJ; Lowe GD
    ASAIO Trans; 1991; 37(4):569-71. PubMed ID: 1768490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation.
    Ovrum E; Fosse E; Mollnes TE; Am Holen E; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
    Eur J Cardiothorac Surg; 1996; 10(1):54-60. PubMed ID: 8776186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of ulinastatin on granulocyte elastase and fibronectin in patients undergoing cardiopulmonary bypass].
    Enzan K; Mitsuhata H; Masaki Y; Matsumoto J; Shigeomi S; Komatsu H; Suzuki M
    Masui; 1991 Nov; 40(11):1625-31. PubMed ID: 1766113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
    Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide inhibits granulocyte responses in healthy humans after ex vivo stimulation with bacterial antigens.
    Juffermans NP; Verbon A; Schultz MJ; Hack CE; van Deventer SJ; Speelman P; van der Poll T
    Antimicrob Agents Chemother; 2001 May; 45(5):1547-9. PubMed ID: 11302825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of lactoferrin and elastase in human allergic skin reactions.
    Zweiman B; Kucich U; Shalit M; Von Allmen C; Moskovitz A; Weinbaum G; Atkins PC
    J Immunol; 1990 May; 144(10):3953-60. PubMed ID: 1692068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of granulocyte enzymes/proteins with immunoassays.
    Lang H; Neumann S; Rautenberg W; Fritz H; Jochum M; Inthorn D
    Prog Clin Biol Res; 1987; 236B():41-9. PubMed ID: 3039528
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithrombin III, leukocyte activation, and low systemic heparinization.
    Ranucci M
    Ann Thorac Surg; 1997 Apr; 63(4):1211-2. PubMed ID: 9124950
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma levels of main granulocyte components during hemodialysis: effects of immunosuppression.
    Riegel W; Leverenz K; Schollmeyer P; Wilms H; Hörl WH
    Nephron; 1987; 46(2):161-6. PubMed ID: 3037400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.